Anti-tumor activity of dual inhibition of phosphatidylinositol 3-kinase and MDM2 against clear cell ovarian carcinoma-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Anti-tumor activity of dual inhibition of phosphatidylinositol 3-kinase and MDM2 against clear cell ovarian carcinoma

Published:2019-11 Issue:2 Volume:155 Page:331-339
ISSN:0090-8258
Container-title:Gynecologic Oncology
language:en
Short-container-title:Gynecologic Oncology

Author:

Makii Chinami,Ikeda Yuji^ORCID,Oda Katsutoshi^ORCID,Uehara Yuriko,Nishijima Akira,Koso Takahiro,Kawata Yoshiko,Kashiyama Tomoko,Miyasaka Aki,Sone Kenbun,Tanikawa Michihiro,Tsuruga Tetsushi,Mori-Uchino Mayuyo,Nagasaka Kazunori,Matsumoto Yoko,Wada-Hiraike Osamu,Kawana Kei,Hasegawa Kosei^ORCID,Fujiwara Keiichi^ORCID,Aburatani Hiroyuki,Osuga Yutaka,Fujii Tomoyuki

Funder

Daiichi Sankyo Co. Ltd.

Grants-in-Aid for Scientific Research

Ministry of Education, Culture, Sports, Science, and Technology of Japan

AMED

Publisher

Elsevier BV

Subject

Obstetrics and Gynaecology,Oncology

Reference40 articles.

1. Gynecologic Cancer InterGroup (GCIG) consensus review for clear cell carcinoma of the ovary;Okamoto;Int. J. Gynecol. Cancer,2014

2. Clear cell epithelial ovarian cancer (mesonephroid): bad prognosis only in early stages;O'Brien;Gynecol. Oncol.,1993

3. Clinical characteristics of clear cell carcinoma of the ovary: a distinct histologic type with poor prognosis and resistance to platinum-based chemotherapy;Sugiyama;Cancer,2000

4. Characterization of TP53 and PI3K signaling pathways as molecular targets in gynecologic malignancies;Oda;J. Obstet. Gynaecol. Res.,2016

5. Phosphatidylinositol 3-kinase: structure and expression of the 110 kd catalytic subunit;Hiles;Cell,1992

Cited by 10 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The unique metabolome of clear cell ovarian carcinoma;The Journal of Pathology;2024-08-03

2. MDM2 Inhibitors for Cancer Therapy: The Past, Present, and Future;Pharmacological Reviews;2024-03-15

3. Treatment for ovarian clear cell carcinoma with combined inhibition of WEE1 and ATR;Journal of Ovarian Research;2023-04-22

4. Efficacy evaluation of multi-immunotherapy in ovarian cancer: From bench to bed;Frontiers in Immunology;2022-10-06

5. Contribution of miRNAs in the Pathogenesis of Breast Cancer;Frontiers in Oncology;2021-11-05

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3